Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study
Christopher M. Bryant, Daniel L. Albertus, Sinae Kim et al. · 2010
Read Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study by Christopher M. Bryant, Daniel L. Albertus, Sinae Kim et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011712.txt.
Description
Christopher Bryant and co-authors sorted lung adenocarcinoma into subtypes defined by cell pathways, in PLOS ONE in 2010. This form of lung cancer is the most common type, yet tumours vary widely in appearance and molecular behaviour. Making sense of that variety is essential if treatments are to be matched to patients.
Drawing on gene expression from hundreds of tumour samples, the team grouped cancers by the pathways driving them. An international validation checked that the grouping held up beyond the original hospitals. Pathway-based subtypes move lung cancer care toward treatment chosen by tumour biology, not appearance alone.
Catalog record
| CREATOR | Christopher M. Bryant, Daniel L. Albertus, Sinae Kim et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011712